Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis

Treatment of multidrug-resistant tuberculosis (MDR-TB) is extremely challenging due to the virulence of the etiologic strains of Mycobacterium tuberculosis (M. tb), the aberrant host immune responses and the diminishing treatment options with TB drugs. New treatment regimens incorporating therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zumla, Alimuddin, Rao, Martin, Dodoo, Ernest, Maeurer, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908783/
https://www.ncbi.nlm.nih.gov/pubmed/27301245
http://dx.doi.org/10.1186/s12916-016-0635-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908783/
https://www.ncbi.nlm.nih.gov/pubmed/27301245
http://dx.doi.org/10.1186/s12916-016-0635-1

Ejemplares similares